Literature DB >> 10214817

Perinatal transmission of human papillomavirus from gravidas with latent infections.

P Tenti1, R Zappatore, P Migliora, A Spinillo, C Belloni, L Carnevali.   

Abstract

OBJECTIVE: To evaluate the risk of perinatal human papillomavirus (HPV) transmission from mothers with latent infections to the oropharyngeal mucosae of their infants.
METHODS: Seven hundred eleven mother-newborn pairs were tested. Polymerase chain reaction was done with MY09/MY11 consensus primers to identify HPV DNA in maternal cervicovaginal lavages and newborn nasopharyngeal aspirates. Positive cases were further amplified with type-specific primers for HPVs 6, 11, 16, 18, and 33. All infants born to HPV-positive mothers were observed to 18 months for appearance of HPV in oropharyngeal mucosae.
RESULTS: Human papillomavirus DNA was detected in 11 neonates born vaginally to HPV-positive women, a vertical transmission rate was 30% (95% confidence interval [CI] 15.9, 47). Nasopharyngeal aspirates were HPV-negative in all 11 cases in which rupture of membranes occurred less than 2 hours before delivery. When rupture preceeded delivery by 2-4 hours, and when it occurred after more than 4 hours, the respective rates for HPV positivity were seven of 21 and four of five (chi2 for trend = 10.7, P = .001). At follow-up, virus was cleared from the oropharyngeal samples as early as the 5th week.
CONCLUSION: Pregnant women with latent HPV infections have low potential of transmitting the virus to the oropharyngeal mucosae of their infants. The time between rupture of the amnion and delivery seems to be a critical factor in predicting transmission. Human papillomavirus-positive infants should be considered contaminated rather than infected since virus is cleared over several months after birth.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10214817     DOI: 10.1016/s0029-7844(98)00459-1

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  22 in total

1.  Asymptomatic genital infection of human papillomavirus in pregnant women and the vertical transmission route.

Authors:  Dongrui Deng; Liangzhen Wen; Wen Chen; Xiazhen Ling
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

2.  Transplacental Transmission of Human Papillomavirus.

Authors:  Anca Florina Zgura; Elvira Bratila; Simona Vladareanu
Journal:  Maedica (Buchar)       Date:  2015-06

Review 3.  [Prophylactic and therapeutic vaccines against human papilloma virus].

Authors:  A E Albers; T K Hoffmann; J P Klussmann; A M Kaufmann
Journal:  HNO       Date:  2010-08       Impact factor: 1.284

4.  Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland.

Authors:  Marjut A M Rintala; Seija E Grénman; Mirja H Puranen; Erika Isolauri; Ulla Ekblad; Pentti O Kero; Stina M Syrjänen
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

5.  Evidence for vertical transmission of HPV from mothers to infants.

Authors:  Elaine M Smith; Michael A Parker; Linda M Rubenstein; Thomas H Haugen; Eva Hamsikova; Lubomir P Turek
Journal:  Infect Dis Obstet Gynecol       Date:  2010-03-14

6.  High-risk human papillomavirus in the oral cavity of women with cervical cancer, and their children.

Authors:  Rajan Saini; Tan P Khim; Sarah A Rahman; Mazian Ismail; Thean H Tang
Journal:  Virol J       Date:  2010-06-16       Impact factor: 4.099

7.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

Review 8.  [Laryngeal papillomatosis: etiology, diagnostics and therapy].

Authors:  M Andratschke; C Betz; A Leunig
Journal:  HNO       Date:  2008-12       Impact factor: 1.284

Review 9.  Recurrent respiratory papillomatosis.

Authors:  Naren N Venkatesan; Harold S Pine; Michael P Underbrink
Journal:  Otolaryngol Clin North Am       Date:  2012-06       Impact factor: 3.346

10.  Perinatal transmission of human papilomavirus DNA.

Authors:  Renato L Rombaldi; Eduardo P Serafini; Jovana Mandelli; Edineia Zimmermann; Kamille P Losquiavo
Journal:  Virol J       Date:  2009-06-21       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.